Ixazomib 2.3 mg, 3 mg, 4 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 2.3 mg, 3 mg, 4 mg
Reference Brands: Ninlaro® (EU & US)
Category: Oncology Cancer Care
Ixazomib Capsules (brand name Ninlaro®) are oral proteasome inhibitors used in multiple myeloma treatment. Available in 2.3 mg, 3 mg, and 4 mg strengths, they are approved in the US and EU and manufactured under GMP standards, offering a convenient and reliable oncology option for B2B pharma partners.
Product Description: Ixazomib Capsules, marketed under the brand name Ninlaro®, are a novel oral proteasome inhibitor used in combination therapies for multiple myeloma in patients who have received at least one prior treatment. Ixazomib works by blocking the 20S proteasome, disrupting protein homeostasis in cancer cells and promoting apoptosis. Available in 2.3 mg, 3 mg, and 4 mg capsule strengths, it provides a convenient oral option for patients and physicians. Manufactured under GMP-compliant facilities, Ixazomib is approved in both the US and EU markets, making it an attractive and effective B2B oncology solution for global pharmaceutical supply chains.
Ixazomib — third party manufacturing & bulk supply
Ixazomib 2.3 mg, 3 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ixazomib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ixazomib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ixazomib →Frequently Asked Questions
Related Products
Venetoclax
Strength:
10 mg, 50 mg, 100 mg
Form: Tablet
Reference Brands: Venclexta® (EU & US)
View DetailsAcalabrutinib
Strength:
100 mg
Form: Oral Capsules
Reference Brands: Calquence® (EU & US)
View DetailsTemozolomide 5 Mg Capsule
Strength:
Capsules: 5 mg, 20 mg, 100 mg, 140 mg; Tablets: 250 mg
Form: Oral Tablets and Oral Capsules
Reference Brands: Temodar® (US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers